Rubius Therapeutics (OTC: RUBY)
Some price data may be temporarily unavailable.
Rubius Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rubius Therapeutics Company Info
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.
News & Analysis
Featured Article
Why Rubius Therapeutics Stock Is Skyrocketing Today
The company announced positive results from a clinical trial.
Prosper Junior Bakiny | Mar 15, 2021
Featured Article
3 High-Risk, High-Reward Stocks to Add to Your Watch List
These biotechs have a long road ahead, but they just might deliver massive growth.
Alex Carchidi | Sep 22, 2020
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.